{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7135,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "section_divider",
      "function": "transition",
      "notes": "The slide features a scientific illustration of cellular structures, likely representing the drug delivery mechanism.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/24",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes scientific diagrams of molecular pathways and efficacy data charts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/25",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Layout splits into three quadrants of charts (survival %, tumor response %, median survival days) plus a navy summary band; Immix Biopharma logo top-right and page number 26 bottom-right.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/26",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes a process diagram showing the mechanism of action of IMX-110 in tumor microenvironments.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/27",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes survival curves (Kaplan-Meier), median survival bar chart, and bioluminescence imaging of tumor growth.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/28",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/29",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes waterfall and spider/line charts for clinical efficacy. Source note at bottom.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/30",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a bubble chart to map clinical trial outcomes against patient treatment history and a table to detail specific drug performance metrics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/31",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart visualizes a single data point (4 months mPFS at 100% of patients with >=3 prior lines of therapy) as a highlighted marker.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/32",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "Shows two parallel tracks: monotherapy and combination therapy with tislelizumab.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/33",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/34",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a process-flow style layout to connect platform capabilities to specific drug candidates.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/35",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a '3 Pillars' framework to explain the platform's foundation, leading into specific product applications.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/36",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes technical diagrams of the drug structure, bar charts for expression, and a Kaplan-Meier survival curve.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/37",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-37",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 38,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes two sets of charts: tumor volume over time and survival curves for MDA-MB-231 and HCT-116 models.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/38",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-38",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 39,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes multiple scientific diagrams and clinical trial data summaries.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/39",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-39",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 40,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/40",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-40",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 41,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide is divided into two sections: ImmixBio Clinical Advisory Board (top) and Selected Nexcella Scientific Advisory Board Members (bottom).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/41",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-41",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 42,
      "slideType": "team_bio",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/42",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-42",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 43,
      "slideType": "team_bio",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/43",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-43",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "appendix",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/44",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-44",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 45,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a bar chart to contrast the combined sales of two groups of oncology drugs ($33.4bn vs $0.9bn).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/45",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-45",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 46,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a bar chart comparison to highlight the efficacy gap between established treatments and placebo, likely to frame the market opportunity for IMX-120.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/46",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-46",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a698-70b1-b3ba-29e176396a9c",
      "docSlug": "63ec8e773c9b43e7b033b64167026114",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 52 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/zIDQMdphoDZCZLvJ7IpcwMwbmZ-6n6rFg98GNRJwz4o/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82M2VjOGU3NzNjOWI0M2U3YjAzM2I2NDE2NzAyNjExNC9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a698-70b1-b3ba-29e176396a9c/1",
      "deckHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c",
      "deckAnchorHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/svCuhHHtW0q1xcu_jV22YfSzkx2t2HT_ISWCs0mcQA4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82M2VjOGU3NzNjOWI0M2U3YjAzM2I2NDE2NzAyNjExNC9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/qE3ySdjP0gGJCG_FzsHoETmKymYsohI7D5wv3k2mq7M/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82M2VjOGU3NzNjOWI0M2U3YjAzM2I2NDE2NzAyNjExNC9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/231x-i0uo4aCI2Qu-0Ft2Y3Iu2qHT0hHDPwvAaOG9vk/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82M2VjOGU3NzNjOWI0M2U3YjAzM2I2NDE2NzAyNjExNC9wMDAxLnBuZw"
    },
    {
      "docId": "019de075-a698-70b1-b3ba-29e176396a9c",
      "docSlug": "63ec8e773c9b43e7b033b64167026114",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 52 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "appendix_disclosure",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a698-70b1-b3ba-29e176396a9c/2",
      "deckHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c",
      "deckAnchorHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a698-70b1-b3ba-29e176396a9c",
      "docSlug": "63ec8e773c9b43e7b033b64167026114",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 52 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "The slide uses a numbered list format to present key value propositions.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a698-70b1-b3ba-29e176396a9c/3",
      "deckHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c",
      "deckAnchorHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a698-70b1-b3ba-29e176396a9c",
      "docSlug": "63ec8e773c9b43e7b033b64167026114",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 52 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a wave-like visual to represent market segments and their associated financial opportunities.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a698-70b1-b3ba-29e176396a9c/4",
      "deckHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c",
      "deckAnchorHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 4,
          "beatId": "7e39c9fb-0b86-4bb6-912e-beac97980ce4",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Description of market opportunity and current limitations",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 5,
          "from": 4,
          "beatId": "daf47eb1-67eb-4ebe-ad97-0646cd1f6f9d",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Size",
          "beatSlug": "sequoia-pitch-market-size",
          "evidence": "Discussion of market potential",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a698-70b1-b3ba-29e176396a9c",
      "docSlug": "63ec8e773c9b43e7b033b64167026114",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 52 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide highlights NXC-201's superior efficacy (100% response rate) and safety profile (zero neurotoxicity) compared to existing therapies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a698-70b1-b3ba-29e176396a9c/5",
      "deckHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c",
      "deckAnchorHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 4,
          "beatId": "7e39c9fb-0b86-4bb6-912e-beac97980ce4",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Description of market opportunity and current limitations",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 5,
          "from": 4,
          "beatId": "daf47eb1-67eb-4ebe-ad97-0646cd1f6f9d",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Size",
          "beatSlug": "sequoia-pitch-market-size",
          "evidence": "Discussion of market potential",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        },
        {
          "to": 8,
          "from": 5,
          "beatId": "e6497832-3875-42e3-a439-0b6eba51fc60",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Competition",
          "beatSlug": "sequoia-pitch-competition",
          "evidence": "Competitive analysis of existing therapies",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a698-70b1-b3ba-29e176396a9c",
      "docSlug": "63ec8e773c9b43e7b033b64167026114",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 52 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide explicitly notes that these are cross-trial comparisons and not head-to-head studies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a698-70b1-b3ba-29e176396a9c/6",
      "deckHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c",
      "deckAnchorHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 4,
          "beatId": "7e39c9fb-0b86-4bb6-912e-beac97980ce4",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Description of market opportunity and current limitations",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 8,
          "from": 5,
          "beatId": "e6497832-3875-42e3-a439-0b6eba51fc60",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Competition",
          "beatSlug": "sequoia-pitch-competition",
          "evidence": "Competitive analysis of existing therapies",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a698-70b1-b3ba-29e176396a9c",
      "docSlug": "63ec8e773c9b43e7b033b64167026114",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 52 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a table structure to contrast standard of care with the company's target segment. The bottom section uses bar charts to imply relative patient population growth.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a698-70b1-b3ba-29e176396a9c/7",
      "deckHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c",
      "deckAnchorHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 4,
          "beatId": "7e39c9fb-0b86-4bb6-912e-beac97980ce4",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Description of market opportunity and current limitations",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 8,
          "from": 5,
          "beatId": "e6497832-3875-42e3-a439-0b6eba51fc60",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Competition",
          "beatSlug": "sequoia-pitch-competition",
          "evidence": "Competitive analysis of existing therapies",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}